Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2016 Jun 30;85(3):400–407. doi: 10.1111/cen.13119

Table 2.

Correlations between individual tumor marker (CgA and PP) and age, sex, PNETs tumor size, tumor number, tumor location, tumor functional status, AJCC stage, lymph node metastases, and lymphovascular invasion.

Characteristic CgA P value PP P value
Age 0.313* 0.081 0.376* 0.049

Tumor size −0.033* 0.861 0.362* 0.063

Tumor number 0.126* 0.500 0.125* 0.535

Sex

(Mean) (SD)
Male 31.6 (191.0) 0.247 2631.4 (8191.2) 0.260
Female 70.7 (199.7) 59.5 (242.1)

Tumor location

(Mean) (SD)
Head/neck −39.8 (45.5) 0.306 132.5 (197.3) 0.268
Body/tail 32.4 (153.4) 1130.4 (5289.1)

Tumor functional status

(Mean) (SD)
F 176.3 (274.7) 0.059 2765.5 (8148.6) 0.019
NF 25.5 (158.1) −15.0 (65.4)

AJCC stage

(Mean) (SD)
I 19.9 (155.1) 0.420 72.6 (330.8) 0.175
II 60.4 (171.6) 99.2 (137.6)

LNM

(Mean) (SD)
Yes 20.0 (80.6) 0.500 107.8 (176.7) 0.671
No 20.0 (150.3) 107.9 (321.0)

LVI

(Mean) (SD)
Yes 14.0 (89.1) 0.767 181.5 (128.0) 0.120
No 39.4 (168.0) 67.8 (273.8)

CgA=chromogranin A; PP=pancreatic polypeptide; PNETs=pancreatic neuroendocrine tumors; AJCC=American Joint Committee on Cancer; F=functioning; NF=non-functioning; LNM=lymph node metastases; LVI=lymphovascular invasion.

*

Spearman correlation